Elena Papaleo

Dr. Elena Papaleo


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
EPElena Papaleo
Elena Papaleo
PMPaolo Mereghetti
Paolo Mereghetti
PFPiercarlo Fantucci
Piercarlo Fantucci
RGRita Grandori
Rita Grandori
LGLuca De Gioia
Luca De Gioia

5 March 2019 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
MMMohamed Mounir
Mohamed Mounir
MLMarta Lucchetta
Marta Lucchetta
TSTiago Chedraoui Silva
Tiago Chedraoui Silva
COCatharina Olsen
Catharina Olsen
Gianluca BontempiGianluca Bontempi
Gianluca Bontempi
EPElena Papaleo
Elena Papaleo
The advent of Next-Generation Sequencing (NGS) technologies has opened new perspectives in deciphering the genetic mechanisms underlying complex diseases. Nowadays, the amount of genomic data is massive and substantial efforts and new tools are required to unveil the information hidden in the data. The Genomic Data Commons (GDC) Data Portal is a platform that contains different genomic studies including the ones from The Cancer Genome Atlas (TCGA) and the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiatives, accounting for more than 40 tumor types originating from nearly 30000 patients. Such platforms, although very attractive, must make sure the stored data are easily accessible and adequately harmonized. Moreover, they have the primary focus on the data storage in a unique place, and they do not provide a comprehensive toolkit for analyses and interpretation of the data. To fulfill this urgent need, comprehensive but easily accessible computational methods for integrative analyses of genomic data that do not renounce a robust statistical and theoretical framework are required. In this context, the R/Bioconductor package TCGAbiolinks was developed, offering a variety of bioinformatics functionalities. Here we introduce new features and enhancements of TCGAbiolinks in terms of i) more accurate and flexible pipelines for differential expression analyses, ii) different methods for tumor purity estimation and filtering, iii) integration of normal samples from other platforms iv) support for other genomics datasets, exemplified here by the TARGET data. Evidence has shown that accounting for tumor purity is essential in the study of tumorigenesis, as these factors promote confounding behavior regarding differential expression analysis. With this in mind, we implemented these filtering procedures in TCGAbiolinks. Moreover, a limitation of some of the TCGA datasets is the unavailability or paucity of corresponding normal samples. We thus integrated into TCGAbiolinks the possibility to use normal samples from the Genotype-Tissue Expression (GTEx) project, which is another large-scale repository cataloging gene expression from healthy individuals. The new functionalities are available in the TCGAbiolinks version 2.8 and higher released in Bioconductor version 3.7. The advent of Next-Generation Sequencing (NGS) technologies has been generating a massive amount of data which require continuous efforts in developing and maintain computational tool for data analyses. The Genomic Data Commons (GDC) Data Portal is a platform that contains different cancer genomic studies. Such platforms have often the primary focus on the data storage and they do not provide a comprehensive toolkit for analyses. To fulfil this urgent need, comprehensive but accessible computational protocols that do not renounce a robust statistical framework are thus required. In this context, we here present the new functions of the R/Bioconductor package TCGAbiolinks to improve the discovery of differentially expressed genes in cancer and tumor (sub)types, include the estimate of tumor purity and tumor infiltrations, use normal samples from other platforms and support more broadly other genomics datasets.

18 February 2016 in Chemical Reviews
Verified
Journal Article
Closed access
EPElena Papaleo
Elena Papaleo
GSGiorgio Saladino
Giorgio Saladino
MLMatteo Lambrughi
Matteo Lambrughi
KLKresten Lindorff-Larsen
Kresten Lindorff-Larsen
FGFrancesco Luigi Gervasio
Francesco Luigi Gervasio
RNRuth Nussinov
Ruth Nussinov

14 September 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ARAnthea Di Rita
Anthea Di Rita
APAngelo Peschiaroli
Angelo Peschiaroli
PDPasquale D′Acunzo
Pasquale D′Acunzo
DSDaniela Strobbe
Daniela Strobbe
ZHZehan Hu
Zehan Hu
FCFrancesco Cecconi
Francesco Cecconi
The selective removal of undesired or damaged mitochondria by autophagy, known as mitophagy, is crucial for cellular homoeostasis, and prevents tumour diffusion, neurodegeneration and ageing. The pro-autophagic molecule AMBRA1 (autophagy/beclin-1 regulator-1) has been defined as a novel regulator of mitophagy in both PINK1/PARKIN-dependent and -independent systems. Here, we identified the E3 ubiquitin ligase HUWE1 as a key inducing factor in AMBRA1-mediated mitophagy, a process that takes place independently of the main mitophagy receptors. Furthermore, we show that mitophagy function of AMBRA1 is post-translationally controlled, upon HUWE1 activity, by a positive phosphorylation on its serine 1014. This modification is mediated by the IKKα kinase and induces structural changes in AMBRA1, thus promoting its interaction with LC3/GABARAP (mATG8) proteins and its mitophagic activity. Altogether, these results demonstrate that AMBRA1 regulates mitophagy through a novel pathway, in which HUWE1 and IKKα are key factors, shedding new lights on the regulation of mitochondrial quality control and homoeostasis in mammalian cells.

25 November 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
FQFederica Quaglia
Federica Quaglia
BMBálint Mészáros
Bálint Mészáros
ESEdoardo Salladini
Edoardo Salladini
AHAndrás Hatos
András Hatos
RPRita Pancsa
Rita Pancsa
DPDamiano Piovesan
Damiano Piovesan
The Database of Intrinsically Disordered Proteins (DisProt, URL: https://disprot.org) is the major repository of manually curated annotations of intrinsically disordered proteins and regions from the literature. We report here recent updates of DisProt version 9, including a restyled web interface, refactored Intrinsically Disordered Proteins Ontology (IDPO), improvements in the curation process and significant content growth of around 30%. Higher quality and consistency of annotations is provided by a newly implemented reviewing process and training of curators. The increased curation capacity is fostered by the integration of DisProt with APICURON, a dedicated resource for the proper attribution and recognition of biocuration efforts. Better interoperability is provided through the adoption of the Minimum Information About Disorder (MIADE) standard, an active collaboration with the Gene Ontology (GO) and Evidence and Conclusion Ontology (ECO) consortia and the support of the ELIXIR infrastructure.

12 November 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AHAndrás Hatos
András Hatos
BHBorbála Hajdu-Soltész
Borbála Hajdu-Soltész
AMAlexander Monzon
Alexander Monzon
NPNicolas Palopoli
Nicolas Palopoli
LÁLucía Álvarez
Lucía Álvarez
DPDamiano Piovesan
Damiano Piovesan
The Database of Protein Disorder (DisProt, URL: https://disprot.org) provides manually curated annotations of intrinsically disordered proteins from the literature. Here we report recent developments with DisProt (version 8), including the doubling of protein entries, a new disorder ontology, improvements of the annotation format and a completely new website. The website includes a redesigned graphical interface, a better search engine, a clearer API for programmatic access and a new annotation interface that integrates text mining technologies. The new entry format provides a greater flexibility, simplifies maintenance and allows the capture of more information from the literature. The new disorder ontology has been formalized and made interoperable by adopting the OWL format, as well as its structure and term definitions have been improved. The new annotation interface has made the curation process faster and more effective. We recently showed that new DisProt annotations can be effectively used to train and validate disorder predictors. We believe the growth of DisProt will accelerate, contributing to the improvement of function and disorder predictors and therefore to illuminate the ‘dark’ proteome.